• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down2.38% Nasdaq Down3.11%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    3.85 Down 0.36(8.55%) 1:52PM EST - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014
    Total Revenue 1,396   1,937   248   41,656  
    Cost of Revenue159  178  (16)160  
    Gross Profit 1,237   1,759   264   41,496  
    Operating Expenses
    Research Development6,766  6,362  6,463  6,728  
    Selling General and Administrative4,235  6,798  3,893  (2,855)
    Non Recurring123  178  42  745  
    Others137  129  132  142  
    Total Operating Expenses11,261  13,467  10,530  4,760  
    Operating Income or Loss (10,024) (11,708) (10,266) 36,736  
    Income from Continuing Operations
    Total Other Income/Expenses Net10  11  12  12  
    Earnings Before Interest And Taxes(10,014)(11,697)(10,254)36,748  
    Interest Expense -   -   -   -  
    Income Before Tax(10,014)(11,697)(10,254)36,748  
    Income Tax Expense -   -   -  (227)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(10,014)(11,697)(10,254)36,975  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (10,014) (11,697) (10,254) 36,975  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (10,014) (11,697) (10,254) 36,975  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.